Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia 60Myelodysplastic Syndromes 53Leukemia, Myeloid, Acute 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Leukemia, Lymphocytic, Chronic, B-Cell 42Lymphoma, Non-Hodgkin 41Hodgkin Disease 38Multiple Myeloma 35Lymphoma, Mantle-Cell 33Lymphoma 33Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Follicular 30Leukemia, Myeloid, Chronic-Phase 30Myeloproliferative Disorders 27Lymphoma, B-Cell, Marginal Zone 27Burkitt Lymphoma 26Congenital Abnormalities 25Lymphoma, Large-Cell, Immunoblastic 24Anemia, Refractory, with Excess of Blasts 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia, Myeloid, Accelerated Phase 21Graft vs Host Disease 21Leukemia, Myelomonocytic, Chronic 20Blast Crisis 19Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 17Recurrence 16Waldenstrom Macroglobulinemia 15Neoplasms, Plasma Cell 15Myelodysplastic-Myeloproliferative Diseases 15

Interventions

posaconazole 1liposomal amphotericin B 1Standard of Care 1Lymphatic Irradiation 1Drug Therapy 1Cyclosporine 1Caspofungin 1Antilymphocyte Serum 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mycoses × Cyclosporine × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡